Full chart
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Market capitalization
31.13 MUSD
—
—
−0.92USD
−7.94 MUSD
2.53 MUSD
5.63 M
Beta (1Y)
0.92
About bioAffinity Technologies, Inc.
Sector
Industry
CEO
Maria Zannes
Website
Headquarters
San Antonio
Employees (FY)
75
Founded
FIGI
BBG00H69JDX1
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Featured
4.4Very Good
Learn more
TradeStation
4.4Very Good
Learn more
The current price of
BIAF
is
2.67
USD
— it has increased by
5.53
% in the past 24 hours. Watch
bioAffinity Technologies, Inc.
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
bioAffinity Technologies, Inc.
stocks are traded under the ticker
BIAF
.
BIAF
stock has risen by
3.49
% compared to the previous week, the month change is a
40.53
% rise, over the last year
bioAffinity Technologies, Inc.
has showed a
57.06
% increase.
We've gathered analysts' opinions on
bioAffinity Technologies, Inc.
future price: according to them,
BIAF
price has a max estimate of
6.00
USD
and a min estimate of
6.00
USD
. Watch
BIAF chartand read a more detailed
bioAffinity Technologies, Inc. stock forecast: see what analysts think of
bioAffinity Technologies, Inc.
and suggest that you do with its stocks.
BIAF
reached its all-time high on
Sep 1, 2022
with the price of
15.55
USD
, and its all-time low was
0.95
USD
and was reached on
Sep 26, 2023
. View more price dynamics on
BIAF chart.
See other stocks reaching their highest and lowest prices.
BIAF
stock is
8.70
% volatile and has beta coefficient of
0.92
. Track
bioAffinity Technologies, Inc.
stock price on the chart and check out the list of the most volatile stocks — is
bioAffinity Technologies, Inc.
there?
Yes, you can track
bioAffinity Technologies, Inc. financialsin yearly and quarterly reports right on TradingView.
bioAffinity Technologies, Inc.
is going to release the next earnings report on
Aug 12, 2024
. Keep track of upcoming events with our Earnings Calendar.
BIAF
earnings for the last quarter are
−0.21
USD
per share, whereas the estimation was
−0.19
USD
resulting in a
−10.53
% surprise. The estimated earnings for the next quarter are
−0.17
USD
per share. See more details about
bioAffinity Technologies, Inc. earnings.
for the last quarter amounts to
2.41 M
USD
, despite the estimated figure of
2.00 M
USD
. In the next quarter, revenue is expected to reach
2.45 M
USD
.
BIAF
net income for the last quarter is
−1.96 M
USD
, while the quarter before that showed
−2.37 M
USD
of net income which accounts for
17.33
% change. Track more
bioAffinity Technologies, Inc. financial statsto get the full picture.
No,
BIAF
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of
Jul 24, 2024
, the company has
75.00
employees. See our rating of the largest employees — is
bioAffinity Technologies, Inc.
on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
bioAffinity Technologies, Inc.
EBITDA is
−7.98 M
USD
, and current EBITDA margin is
−304.98
%. See more stats in
bioAffinity Technologies, Inc. financial statements.
Like other stocks,
BIAF
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
bioAffinity Technologies, Inc.
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
bioAffinity Technologies, Inc.
technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
bioAffinity Technologies, Inc.
stock shows the strong buy signal. See more of
bioAffinity Technologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.